Host targeted adjunctive therapies to boost antimalarial immunity [ 1/1/2021 - 12/31/2022 ]

Research Grant

Brief description Malaria caused 200 million cases and 400000 deaths in 2018. One problem in developing new control strategies for malaria is that following a malaria infection, individuals develop disruptive immune responses that block vaccines. Our project investigates the ability of a repurposed drug to prevent the development of disruptive immune responses during malaria in humans. Results of our studies will inform the development of new malaria control tools.

Funding Amount $2,060,189

Funding Scheme Ideas Grants

Chief Investigator Dr Michelle Boyle

Notes Ideas Grants